Myriad Genetics partners with AWS to enhance Image Genius, speeding up document processing, and improving insurance workflows for diagnostics.

SOPHiA GENETICS is back in focus as analysts reset their central price views, with fair value moving from US$9.00 to US$9.75. Recent research linking the company’s role in data driven oncology and ...

Opus Genetics (IRD) receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in ...

SOPHiA GENETICS SA SOPH shares rallied 7% in the last trading session to close at $8.53. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Opus Genetics, Inc. (NASDAQ:IRD) reported on September 9 that all five low-dose BIRD-1 participants showed clinically ...

Understanding gene regulation may be key to interpreting human disease genetics. Genes are regulated in part by stretches of ...

The average one-year price target for Opus Genetics (NASDAQCM:IRD) has been revised to $12.98 / share. This is an increase of 21.47% from the prior estimate of $10.68 dated August 25, 2026. These ...

Genetics is the study of genes and how they influence characteristics and health. Through a variety of technological methods, environmental factors, and lifestyle choices, it is possible to alter some ...

A genetic testing company's data breach is particularly problematic for people undergoing IVF, experts warned.